Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
CRYSTALLINE SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE

No-Receipt date 2016-01796 - 16/06/2016
No-Filing date 20160401283 - 16/06/2016
No-Granting date 3088970 - 28/06/2016
No-EPO application date 13198120.1 - 12/06/2008
No-EPO granting date 2740731 - 23/03/2016
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 6/2016 - 29/07/2016
Expiration date 13/06/2028
Kind of title Validation of European Patent
Legal status VALID
Priorities US943705 P13/06/2007/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
C07D 487/04
A61K 31/519

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
667443 INCYTE HOLDINGS CORPORATION 1801 AUGUSTINE CUT-OFFWILMINGTON, DE 19803 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
1628432 LI, HUI-YIN
1628433 RODGERS, JAMES, D.

Representatives
CodeFirstnameSurnameAddressTownZip
3190KONSTANTINOSKILIMIRIS "PATRINOS & KILIMIRIS DIKIGORIKI ETAIRIA"CHATZIGIANNI MEXI 7ATHINA (ATTIKIS)11528

Contact
CodeFirstnameSurnameAddressTownZipCountry
8149KONSTANTINOSKILIMIRISCHATZIGIANNI MEXI 7ATHINA (ATTIKIS)11528 GREECE

Owners History

Title Instruments
DateOperationDescreption
9/19/2024 12:00:00 AMΔιάφορες Μεταβολές (70004) ΑΡ.ΠΡΩΤ. 23076/2024 (ΑΡ.ΥΠΟΘ. 3345/2024) ΠΛΗΡΕΞ. ΔΙΚΗΓΟΡΟΣ ΚΩΝ. ΚΙΛΙΜΙΡΗΣ (Η ΔΙΚΑΙΟΥΧΟΣ ΕΤΑΙΡΕΙΑ ΠΑΡΑΧΩΡΗΣΕ ΑΠΟΚΛΕΙΣΤΙΚΗ ΑΔΕΙΑ ΕΚΜΕΤΑΛΛΕΥΣΗΣ ΤΗΝ NOVARTIS PHARMA AG με έδρα την Lichtstrasse 35, 4056 Basel, SWITZERLAND)

Payments history 18 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015
 
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).